Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
European Journal of Cancer (Oxford, England : 1990)|December 3, 2014
A randomised, open-label phase II trial of afatinib versus cetuximab in patients with metastatic colorectal cancerTamas Hickish, Jim Cassidy, David Propper, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 1, 2013
Thymidylate synthase expression and outcome of patients receiving pemetrexed for advanced nonsquamous non-small-cell lung cancer in a prospective blinded assessment phase II clinical trialMarianne C Nicolson, Dean A Fennell, David Ferry, et al.Lung Cancer (Amsterdam, Netherlands)|August 19, 2018
Adjuvant treatment patterns and outcomes in patients with stage IB-IIIA non-small cell lung cancer in France, Germany, and the United Kingdom based on the LuCaBIS burden of illness studyChristos Chouaid, Sarah Danson, Stefan Andreas, et al.Lung Cancer (Amsterdam, Netherlands)|July 3, 2018
Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS)Stefan Andreas, Christos Chouaid, Sarah Danson, et al.Lung Cancer (Amsterdam, Netherlands)|March 8, 2025
Osimertinib long-term tolerability in patients with EGFRm NSCLC enrolled in the AURA program or FLAURA studyMarina Chiara Garassino, Yong He, Myung-Ju Ahn, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 27, 2015
Safety and Immunogenicity of MAGE-A3 Cancer Immunotherapeutic with or without Adjuvant Chemotherapy in Patients with Resected Stage IB to III MAGE-A3-Positive Non-Small-Cell Lung CancerJean-Louis Pujol, Johan F Vansteenkiste, Tommaso Martino De Pas, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2013
Sorafenib in combination with oxaliplatin, leucovorin, and fluorouracil (modified FOLFOX6) as first-line treatment of metastatic colorectal cancer: the RESPECT trialJosep Tabernero, Rocio Garcia-Carbonero, James Cassidy, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 12, 2024
Tissue-Free Liquid Biopsies Combining Genomic and Methylation Signals for Minimal Residual Disease Detection in Patients with Early Colorectal Cancer from the UK TRACC Part B StudySusanna Slater, Annette Bryant, Maria Aresu, et al.The Journal of Pathology|November 15, 2023
Genetic and immune landscape evolution in MMR-deficient colorectal cancerBenjamin R Challoner, Andrew Woolston, David Lau, et al.JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.Pageof 2